Modified ragweed tyrosine adsorbate - Allergy Therapeutics
Alternative Names: POLLINEX-R; Pollinex® Quattro Ragweed; PQ Ragweed; Pr POLLINEX -R; R-301; Ragweed MATA MPLLatest Information Update: 20 Sep 2024
At a glance
- Originator Allergy Therapeutics
- Class Antiallergics; Plant allergy immunotherapies
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Registered Ragweed pollen hypersensitivity
Most Recent Events
- 08 May 2019 Pollinex Quattro ragweed is still in phase III trials for Ragweed pollen hypersensitivity in USA and Canada (Allergy Therapeutics pipeline, May 2019)